OSA is a prevalent yet underdiagnosed disease, currently affecting over 50 million adults in the United States, yet up to 80% of cases ...
By reducing acute care costs and improving management of high-cost comorbidities, PAP therapy offers a compelling opportunity to reduce ...
Immediate action is needed by multiple sleep stakeholders to ensure the future burden of OSA can be clinically managed by sleep specialists ...
Hear from Dr. Jonna Morris about diagnostic and screening blind spots surrounding women and OSA.
Dr. Jonna Morris explains how language and reporting patterns affect OSA presentation in women, and why many remain overlooked.
Hear from Prof. Winfried Randerath about the adoption of the Baveno classification into clinical practice and the role of primary care in ...
Hear from Prof. Winfried Randerath what impact the modified Baveno classification has for women, people with mild OSA and others.
Hear from Prof. Winfried Randerath how and why AHI has been added to the modified Baveno classification and its impact on patients.
Hear from Prof. Winfried Randerath how the Baveno classification has been modified to more effectively categorize patients with sleep apnea.
AHI as the sole or primary OSA diagnostic criteria puts too many people at risk by preventing treatment for those who need it.
The AHI and OSA are deeply intertwined, but questions have been asked about AHI as a metric of OSA diagnosis and classification from the ...
A growing body of research shows how gender biases and stereotypes of obstructive sleep apnea stand in the way of women receiving the help ...
Privacy|Terms of use |©2025 Resmed|All rights reserved
